Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1309
| Despition | CCR5 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1533 | Human NREP Protein (AC1533) | 2 µg | inquiry |
| ACPP-1439 | Human NHLH1 Protein (AC1439) | 1 µg | inquiry |
| ACPP-1601 | Rat ACRP30 Protein (AC1601) | 2 µg | inquiry |
| ACPP-1808 | Human LIF Protein, Yeast (AC1808) | 5 µg | inquiry |
| ACPP-1495 | Cofilin Blocking Peptide (AC1495) | 250 µg | inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg | inquiry |
| ACPP-1719 | Human FDFT1 Protein (AC1719) | 2 µg | inquiry |
| ACPP-1368 | KCNJ2 Blocking Peptide (AC1368) | 250 µg | inquiry |
| ACPP-1199 | Beta crystallin S Blocking Peptide (AC1199) | 250 µg | inquiry |
| ACPP-1258 | Pannexin 1 Blocking Peptide (AC1258) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.